Treatment of Single Maxillary Gingival Recession With Loss of Inter-dental Attachment. A Randomized Controlled Clinical Trial
Launched by UNIVERSITY OF FLORENCE · Jul 11, 2022
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Smoking \< 20 cigarettes/day.
- • Full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) \< 15% (measured at four sites per tooth).
- • Presence of at least one RT2 (Cairo et al. 2011) buccal gingival recession \> 2 mm of depth
- • Only gingival recessions localized at upper central and lateral incisors, canine, and first and second pre-molars associated with aesthetic problems and/ordental hypersensitivity were considered.
- • Presence of an identifiable CEJ
- Exclusion Criteria:
- • Systemic diseases or pregnancy.
- • Systemic antibiotic therapy in the last 6 months.
- • Active periodontal disease with sites showing probing depth \>4 mm.
About University Of Florence
The University of Florence is a leading academic institution in Italy, renowned for its commitment to advancing scientific research and education in the medical field. With a rich history of innovation and collaboration, the university actively engages in clinical trials aimed at improving healthcare outcomes. Its multidisciplinary approach integrates cutting-edge research with clinical practice, fostering an environment that encourages the development of new therapies and treatment protocols. The University of Florence is dedicated to enhancing patient care through rigorous scientific inquiry and ethical standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Florence, Tuscany, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials